Luteolin combined with entecavir inhibits hepatitis B virus replication by regulating the Keap1/Nrf2/ARE signaling pathway

LUO Dan, LI Xi, PAN Shu, LI Huadong

China Tropical Medicine ›› 2026, Vol. 26 ›› Issue (2) : 259-266.

PDF(1285 KB)
PDF(1285 KB)
China Tropical Medicine ›› 2026, Vol. 26 ›› Issue (2) : 259-266. DOI: 10.13604/j.cnki.46-1064/r.2025-1109
Articles

Luteolin combined with entecavir inhibits hepatitis B virus replication by regulating the Keap1/Nrf2/ARE signaling pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 26(2): 259-266 https://doi.org/10.13604/j.cnki.46-1064/r.2025-1109

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1285 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉